Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Mon Mar 31 20:36:50 GMT 2025
by
admin
on
Mon Mar 31 20:36:50 GMT 2025
|
| Protein Type | GROWTH FACTOR |
| Protein Sub Type | ERYTHROPOIETIN |
| Sequence Origin | HUMAN |
| Sequence Type | COMPLETE |
| Record UNII |
64FS3BFH5W
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Related Record | Type |
|---|
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QB03XA01
Created by
admin on Mon Mar 31 20:36:50 GMT 2025 , Edited by admin on Mon Mar 31 20:36:50 GMT 2025
|
||
|
FDA ORPHAN DRUG |
18987
Created by
admin on Mon Mar 31 20:36:50 GMT 2025 , Edited by admin on Mon Mar 31 20:36:50 GMT 2025
|
||
|
WHO-ATC |
B03XA01
Created by
admin on Mon Mar 31 20:36:50 GMT 2025 , Edited by admin on Mon Mar 31 20:36:50 GMT 2025
|
||
|
NDF-RT |
N0000008193
Created by
admin on Mon Mar 31 20:36:50 GMT 2025 , Edited by admin on Mon Mar 31 20:36:50 GMT 2025
|
||
|
NDF-RT |
N0000008193
Created by
admin on Mon Mar 31 20:36:50 GMT 2025 , Edited by admin on Mon Mar 31 20:36:50 GMT 2025
|
||
|
FDA ORPHAN DRUG |
17886
Created by
admin on Mon Mar 31 20:36:50 GMT 2025 , Edited by admin on Mon Mar 31 20:36:50 GMT 2025
|
||
|
NDF-RT |
N0000009319
Created by
admin on Mon Mar 31 20:36:50 GMT 2025 , Edited by admin on Mon Mar 31 20:36:50 GMT 2025
|
||
|
NDF-RT |
N0000175665
Created by
admin on Mon Mar 31 20:36:50 GMT 2025 , Edited by admin on Mon Mar 31 20:36:50 GMT 2025
|
||
|
FDA ORPHAN DRUG |
341711
Created by
admin on Mon Mar 31 20:36:50 GMT 2025 , Edited by admin on Mon Mar 31 20:36:50 GMT 2025
|
||
|
NDF-RT |
N0000008193
Created by
admin on Mon Mar 31 20:36:50 GMT 2025 , Edited by admin on Mon Mar 31 20:36:50 GMT 2025
|
||
|
NDF-RT |
N0000008193
Created by
admin on Mon Mar 31 20:36:50 GMT 2025 , Edited by admin on Mon Mar 31 20:36:50 GMT 2025
|
||
|
NDF-RT |
N0000008193
Created by
admin on Mon Mar 31 20:36:50 GMT 2025 , Edited by admin on Mon Mar 31 20:36:50 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
64FS3BFH5W
Created by
admin on Mon Mar 31 20:36:50 GMT 2025 , Edited by admin on Mon Mar 31 20:36:50 GMT 2025
|
PRIMARY | |||
|
DB00016
Created by
admin on Mon Mar 31 20:36:50 GMT 2025 , Edited by admin on Mon Mar 31 20:36:50 GMT 2025
|
PRIMARY | |||
|
4921
Created by
admin on Mon Mar 31 20:36:50 GMT 2025 , Edited by admin on Mon Mar 31 20:36:50 GMT 2025
|
PRIMARY | |||
|
m5014
Created by
admin on Mon Mar 31 20:36:50 GMT 2025 , Edited by admin on Mon Mar 31 20:36:50 GMT 2025
|
PRIMARY | Merck Index | ||
|
2047589
Created by
admin on Mon Mar 31 20:36:50 GMT 2025 , Edited by admin on Mon Mar 31 20:36:50 GMT 2025
|
PRIMARY | |||
|
SUB13707MIG
Created by
admin on Mon Mar 31 20:36:50 GMT 2025 , Edited by admin on Mon Mar 31 20:36:50 GMT 2025
|
PRIMARY | |||
|
DTXSID7039678
Created by
admin on Mon Mar 31 20:36:50 GMT 2025 , Edited by admin on Mon Mar 31 20:36:50 GMT 2025
|
PRIMARY | |||
|
D004921
Created by
admin on Mon Mar 31 20:36:50 GMT 2025 , Edited by admin on Mon Mar 31 20:36:50 GMT 2025
|
PRIMARY | |||
|
64FS3BFH5W
Created by
admin on Mon Mar 31 20:36:50 GMT 2025 , Edited by admin on Mon Mar 31 20:36:50 GMT 2025
|
PRIMARY | |||
|
234-317-2
Created by
admin on Mon Mar 31 20:36:50 GMT 2025 , Edited by admin on Mon Mar 31 20:36:50 GMT 2025
|
PRIMARY | |||
|
1248218
Created by
admin on Mon Mar 31 20:36:50 GMT 2025 , Edited by admin on Mon Mar 31 20:36:50 GMT 2025
|
PRIMARY | |||
|
m5014
Created by
admin on Mon Mar 31 20:36:50 GMT 2025 , Edited by admin on Mon Mar 31 20:36:50 GMT 2025
|
PRIMARY | Merck Index | ||
|
m5014
Created by
admin on Mon Mar 31 20:36:50 GMT 2025 , Edited by admin on Mon Mar 31 20:36:50 GMT 2025
|
PRIMARY | Merck Index | ||
|
m5014
Created by
admin on Mon Mar 31 20:36:50 GMT 2025 , Edited by admin on Mon Mar 31 20:36:50 GMT 2025
|
PRIMARY | Merck Index | ||
|
m5014
Created by
admin on Mon Mar 31 20:36:50 GMT 2025 , Edited by admin on Mon Mar 31 20:36:50 GMT 2025
|
PRIMARY | Merck Index | ||
|
ErythropoiesisStimulatingAgent
Created by
admin on Mon Mar 31 20:36:50 GMT 2025 , Edited by admin on Mon Mar 31 20:36:50 GMT 2025
|
PRIMARY | |||
|
11751549
Created by
admin on Mon Mar 31 20:36:50 GMT 2025 , Edited by admin on Mon Mar 31 20:36:50 GMT 2025
|
PRIMARY | |||
|
6384
Created by
admin on Mon Mar 31 20:36:50 GMT 2025 , Edited by admin on Mon Mar 31 20:36:50 GMT 2025
|
PRIMARY | |||
|
C477
Created by
admin on Mon Mar 31 20:36:50 GMT 2025 , Edited by admin on Mon Mar 31 20:36:50 GMT 2025
|
PRIMARY | |||
|
11096-26-7
Created by
admin on Mon Mar 31 20:36:50 GMT 2025 , Edited by admin on Mon Mar 31 20:36:50 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_7 | 1_161 |
| 1_29 | 1_33 |
| Glycosylation Type | MAMMALIAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_24 |
| N | 1_38 |
| N | 1_83 |
| O | 1_126 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SUB_CONCEPT->SUBSTANCE | |||
|
|
SUB_CONCEPT->SUBSTANCE | |||
|
BIOSIMILAR -> PARENT |
|
||
|
|
SUB_CONCEPT->SUBSTANCE | |||
|
|
SUB_CONCEPT->SUBSTANCE | |||
|
|
SUB_CONCEPT->SUBSTANCE | |||
|
|
SUB_CONCEPT->SUBSTANCE | |||
|
|
SUB_CONCEPT->SUBSTANCE | |||
|
|
ACTIVATOR OF EXPRESSION->TARGET |
|
||
|
|
SUB_CONCEPT->SUBSTANCE | |||
|
|
SUB_CONCEPT->SUBSTANCE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:SDS-PAGE | CHEMICAL |
|
||||
| Molecular Formula | CHEMICAL |
|